FDA inspection
Eurofins Biopharma Product Testing India Private Ltd.: FDA inspection ending Feb 27, 2019
FDA inspection 1085309 · No Action Indicated (NAI) · Bengaluru
Key facts
| Inspection ID | 1085309 |
|---|---|
| Firm | Eurofins Biopharma Product Testing India Private Ltd. |
| FEI number | 3013200240 |
| Address | 7 Pugazhendi Street |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Feb 27, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data